US private equity firm TPG Inc has completed its majority investment in iNova Pharmaceuticals, an independent consumer healthcare and medicine products company in the Asia-Pacific, alongside co-investors, according to an announcement.
The transaction value was not disclosed. Existing iNova investor, Pacific Equity Partners (PEP), has re-invested from its new fund as a minority stakeholder.
